Benzoxazole Derivatives as Promising Antitubercular Agents

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F18%3A73591160" target="_blank" >RIV/61989592:15110/18:73591160 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15310/18:73591160
Result on the web
<a href="http://dx.doi.org/10.1002/slct.201800631" target="_blank" >http://dx.doi.org/10.1002/slct.201800631</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/slct.201800631" target="_blank" >10.1002/slct.201800631</a>

Result language
angličtina
Original language name
Benzoxazole Derivatives as Promising Antitubercular Agents
Original language description
Tuberculosis (TB) is an infectious disease caused predominantly by bacillus Mycobacterium tuberculosis (MTB). The increasing prevalence of multidrug-resistant MTB necessitates the discovery and development of alternative drugs against tuberculosis with a new mechanism of action. Over the past years, several benzoxazole derivatives have been synthesized and screened for their biological activity. Interestingly, some of them had promising antitubercular activity. Despite that, none of the benzoxazole derivatives has entered the phase of the preclinical hit-to-lead optimization step in anti-TB research. In this review, we are summarizing recently published articles that evaluate the potency of benzoxazole heterocycle in the development of novel anti-TB agents and outlined the future aspects of this promising heterocycle.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10401 - Organic chemistry

Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)